CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Tumor progression involves complex interactions between cancer cells and their surrounding microenvironment.
• The tumor matrix plays a critical role in supporting metastasis.
• Previous work showed CD44v6-competent tumor matrix supports metastasis, unlike CD44v6-deficient matrix.

Purpose of the Study:

• To investigate the feedback mechanism between the tumor matrix and tumor cells.
• To elucidate the role of CD44v6 in orchestrating signals from the tumor matrix.
• To understand how CD44v6 influences tumor cell motility and apoptosis resistance.

Main Methods:

• Comparison of matrix composition (hyaluronan synthase-3, hyaluronidase, high molecular weight hyaluronan) between CD44v6-competent and deficient tumor cells.
• Assessing tumor cell migration and apoptosis resistance on matrices from different cell lines.
• Investigating signaling pathways (c-Met, α6β4, FAK, PI3K/Akt, MAPK) involved in CD44v6-mediated effects.
• Validating findings in human tumor lines.

Main Results:

• CD44v6-competent tumor matrix supports cell migration and apoptosis resistance, unlike CD44v6-deficient matrix.
• CD44v6-competent cells exhibit higher hyaluronan synthase-3 and secrete more high molecular weight hyaluronan.
• CD44v6 deficiency impairs matrix-initiated signaling cascades, including those involving c-Met and α6β4.
• CD44v6 is crucial for augmenting c-Met and α6β4 signaling for motility and apoptosis resistance.
• These CD44v6-dependent mechanisms are conserved in human tumor lines.

Conclusions:

• CD44v6 is essential for tumor progression by regulating matrix composition and orchestrating matrix-derived signals.
• CD44v6 promotes tumor cell motility and apoptosis resistance through a feedback loop involving the tumor matrix and intracellular signaling pathways.
• The findings highlight CD44v6 as a potential therapeutic target for inhibiting cancer metastasis.